Anna Jargieło

Dr. Anna Jargieło


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2026 in Polish Heart Journal
Verified
Journal Article
Closed access
AOArtur OręZiak
Artur OręZiak
AJAnna Jargieło
Anna Jargieło
FMFilip Machaj
Filip Machaj
PMPatryk Marchewka
Patryk Marchewka
ARAnna Rysiak
Anna Rysiak
JZJoanna Zakrzewska-Koperska
Joanna Zakrzewska-Koperska

Verified
Journal Article
Open access
PDF file
MDMichalina Dworak Maria Dworak
Michalina Dworak Maria Dworak
KJKrzysztof Jaworski
Krzysztof Jaworski
KKKacper Karaban
Kacper Karaban
AWAnna Wałachowska
Anna Wałachowska
EŚEwa Świerżyńska
Ewa Świerżyńska
MSMaciej Sterliński
Maciej Sterliński
Mitral valve prolapse (MVP) and mitral annular disjunction (MAD) are common comorbidities that can lead to serious cardiac arrhythmias and sudden cardiac death (SCD). Arrhythmic MVP is characterized by the presence of MVP with frequent (over 5% ventricular extra beats) and/or complex ventricular arrhythmias, such as ventricular tachycardia (VT), non-sustained VT, or ventricular fibrillation in the absence of other causes of arrhythmia, e.g., post-infarction scar, recent ischemia, channelopathy, or cardiomyopathy. The mechanisms of the development of serious cardiac arrhythmias in patients with MVP and MAD are not fully understood. Arrhythmic MVP may be an indication for cardioverter defibrillator implantation. Considering the increased risk of SCD in this group of patients, the pathophysiology of this valvular dysfunction and characteristic deviations in diagnostic tests that indicate a higher risk of SCD are presented. The issue of tailored risk stratification in individual patients is crucial.

14 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JMJakub Malinowski
Jakub Malinowski
ŁNŁukasz Nowotka
Łukasz Nowotka
Jakub Kosma RokickiJakub Kosma Rokicki
Jakub Kosma Rokicki
OWOlgierd Woźniak
Olgierd Woźniak
PSPaweł Syska
Paweł Syska
MKMirosław Kowalski
Mirosław Kowalski
Background: Evidence to guide risk stratification after ICD implantation in adults with congenital heart disease (ACHD) is limited. We sought predictors of appropriate ICD intervention in this population. Methods: Consecutive ACHD patients implanted with an ICD (2009–2023) were analysed retrospectively. Time to first appropriate ICD intervention was modelled from a single, consistently defined start of observation. Because only 24 events were available, candidate predictors were pre-specified and each model limited to two covariates; sparse predictors used Firth penalisation, and multiplicity was addressed by the Benjamini–Hochberg false discovery rate procedure. Results: Among 56 patients (73.2% male; 22 primary and 34 secondary prevention), appropriate intervention occurred in 24 (42.9%) over a median follow-up of 51.9 months. Atrial fibrillation (HR 2.75, 95% CI 1.22–6.23) and radiographic cardiomegaly (HR 3.99, 95% CI 1.28–12.40) showed the largest unadjusted associations, whereas individual congenital lesions and disease-severity descriptors did not. No predictor remained significant after Benjamini–Hochberg correction (q ≈ 0.10). The very high hazard ratios for sparsely represented thyroid disorders (hypothyroidism, n = 2; hyperthyroidism, n = 4) were unstable under penalised estimation and are reported as exploratory. A pre-specified two-variable model (atrial fibrillation plus radiographic cardiomegaly) showed modest discrimination (optimism-corrected Harrell’s C-index 0.63). Conclusions: In a heterogeneous real-world ACHD cohort, a history of atrial fibrillation and radiographic cardiomegaly were associated with appropriate ICD intervention. Given the small number of events and the sparsity of several predictors, these findings should be regarded as hypothesis-generating and require validation in larger multicentre ACHD cohorts.